Insider Transactions in Q1 2021 at Arcutis Biotherapeutics, Inc. (ARQT)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
10,000
-0.57%
|
$310,000
$31.1 P/Share
|
|
Mar 16
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,653
+0.42%
|
$2,653
$1.31 P/Share
|
|
Mar 10
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
1,250
-1.42%
|
$40,000
$32.9 P/Share
|
|
Mar 10
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.07%
|
$16,000
$32.9 P/Share
|
|
Mar 10
2021
|
John W Smither Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.06%
|
$500
$1.68 P/Share
|
|
Mar 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,750
-0.29%
|
$52,500
$30.55 P/Share
|
|
Mar 04
2021
|
John W Smither Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,396
+21.11%
|
$12,396
$1.68 P/Share
|
|
Mar 03
2021
|
Patricia A. Turney SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+33.6%
|
-
|
|
Mar 03
2021
|
David W Osborne Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+3.71%
|
-
|
|
Mar 03
2021
|
Kenneth A. Lock Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+23.08%
|
-
|
|
Mar 03
2021
|
Patrick Burnett Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+50.0%
|
-
|
|
Mar 03
2021
|
John W Smither Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+21.88%
|
-
|
|
Mar 03
2021
|
Todd Franklin Watanabe Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+5.18%
|
-
|
|
Mar 02
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
2,107
-0.37%
|
$73,745
$35.19 P/Share
|
|
Mar 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.53%
|
$74,800
$34.61 P/Share
|
|
Mar 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.35%
|
$6,600
$3.29 P/Share
|
|
Mar 01
2021
|
Kenneth A. Lock Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
933
-4.04%
|
$31,722
$34.2 P/Share
|
|
Mar 01
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
773
-3.07%
|
$26,282
$34.2 P/Share
|
|
Mar 01
2021
|
Patricia A. Turney SVP, Operations |
SELL
Open market or private sale
|
Direct |
934
-9.15%
|
$31,756
$34.52 P/Share
|
|
Mar 01
2021
|
David W Osborne Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
780
-0.33%
|
$26,520
$34.57 P/Share
|
|
Feb 22
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
10,000
-0.56%
|
$350,000
$35.66 P/Share
|
|
Feb 16
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,654
+0.43%
|
$2,654
$1.31 P/Share
|
|
Feb 10
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
2,000
-2.22%
|
$70,000
$35.64 P/Share
|
|
Feb 10
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
750
-2.89%
|
$26,250
$35.64 P/Share
|
|
Feb 10
2021
|
John W Smither Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+2.81%
|
$750
$1.68 P/Share
|
|
Feb 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
10,000
-0.87%
|
$340,000
$34.13 P/Share
|
|
Feb 05
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.7%
|
$10,000
$1.68 P/Share
|
|
Feb 04
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,861
+4.58%
|
$19,861
$1.68 P/Share
|
|
Feb 01
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
3,750
-4.0%
|
$131,250
$35.0 P/Share
|
|
Feb 01
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,250
-4.73%
|
$43,750
$35.0 P/Share
|
|
Feb 01
2021
|
John W Smither Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+4.51%
|
$1,250
$1.68 P/Share
|
|
Feb 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.3%
|
$74,800
$34.74 P/Share
|
|
Feb 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.59%
|
$2,200
$1.68 P/Share
|
|
Feb 01
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
9,949
-1.1%
|
$328,317
$33.25 P/Share
|
|
Jan 29
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
51
-0.01%
|
$1,377
$27.5 P/Share
|
|
Jan 19
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
1,250
-1.32%
|
$37,500
$30.0 P/Share
|
|
Jan 19
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.95%
|
$15,000
$30.0 P/Share
|
|
Jan 19
2021
|
John W Smither Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.91%
|
$500
$1.68 P/Share
|
|
Jan 12
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,222
+0.66%
|
$0
$0.58 P/Share
|
|
Jan 04
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-1.2%
|
$59,400
$27.82 P/Share
|
|
Jan 04
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.59%
|
$2,200
$1.68 P/Share
|